Skip to main content
. Author manuscript; available in PMC: 2012 Aug 7.
Published in final edited form as: Future Med Chem. 2011 Jun;3(8):1057–1085. doi: 10.4155/fmc.11.63

Figure 3. Examples of pharmacophores used in ligand-based virtual screening.

Figure 3

(A) A pharmacophore produced by Catalyst. Blue sphere: hydrophobic feature; green sphere: hydrogen-bond acceptor; purple sphere: hydrogen-bond donor; black sphere: excluded volume. (B) A pharmacophore produced by Phase. Light red sphere: hydrogen-bond acceptor; light blue sphere: hydrogen-bond donor; green sphere: hydrophobic feature; red sphere: negative feature; orange torus: aromatic ring.

HHS Vulnerability Disclosure